HomeALIVUS • NSE
add
Alivus Life Sciences Ltd
Previous close
₹887.65
Day range
₹881.40 - ₹904.65
Year range
₹847.20 - ₹1,251.00
Market cap
110.41B INR
Avg Volume
114.39K
P/E ratio
20.86
Dividend yield
0.56%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.88B | 16.00% |
Operating expense | 1.78B | 9.80% |
Net income | 1.30B | 36.42% |
Net profit margin | 22.11 | 17.61% |
Earnings per share | 10.58 | 36.52% |
EBITDA | 1.78B | 33.19% |
Effective tax rate | 25.33% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.53B | 46.27% |
Total assets | 36.38B | 17.94% |
Total liabilities | 6.23B | 14.02% |
Total equity | 30.15B | — |
Shares outstanding | 122.67M | — |
Price to book | 3.61 | — |
Return on assets | — | — |
Return on capital | 13.51% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 1.30B | 36.42% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2001
Website
Employees
2,203
